<qa>  What is the sensitivity of the patient to paclitaxel?1. Known sensitivity to paclitaxel 2. Any previous or planned treatment with a non-study anti-restenotic drug-coated or drug-eluting coronary stent. Note: previous or planned treatment with heparin or phosphorylcholine coated stents is acceptable, as long as the procedure with the non-study stent meets the protocol defined criteria for staged procedures 3. Previous or planned treatment with intravascular brachytherapy in the target vessel 4. MI within 72 hours prior to the index procedure andor CK-MB 2x the local laboratorys upper limits of normal refers to a measured value on the day of the index procedure 5. Cerebrovascular Accident CVA within the past 6 months 6. Acute or chronic renal dysfunction creatinine 2.0 mgdl or 150 μmolL 7. Contraindication to ASA, or to both clopidogrel and ticlopidine 8. Leukopenia leukocyte count 3.5 x 109liter 9. Thrombocytopenia platelet count 100,000mm3 10. Active peptic ulcer or active gastrointestinal GI bleeding 11. Known allergy to stainless steel 12. Any prior true anaphylactic reaction to contrast agents 13. Known anaphylactoid or other non-anaphylactic allergic reactions to contrast agents that cannot be adequately pre-medicated prior to the index procedure 14. Patient is currently taking colchicine 15. Patient is currently, or has been treated with paclitaxel within 12 months of the index procedure 16. Female of childbearing potential with a positive pregnancy test within 7 days before the index procedure, or lactating, or intends to become pregnant during the study 17. Life expectancy of less than 24 months due to other medical conditions 18. Co-morbid conditions that could limit the patients ability to participate in the study, compliance with follow-up requirements or impact the scientific integrity of the study 19. Currently participating in another investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the endpoints of this study 